2019
DOI: 10.1007/s00403-019-01979-w
|View full text |Cite
|
Sign up to set email alerts
|

Ultrastructural characterization of damage in the basement membrane of facial melasma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
2
1

Relationship

5
5

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 19 publications
0
18
0
1
Order By: Relevance
“…Mast cells also secret paracrine mediators factors that induce elastin production by fibroblasts 18 . In addition, mast cells produce tryptase, which participate in the damage to the extracellular matrix and basement membrane, (through matrix metallopeptidases 9-collagen IV damage), what can influence the occurrence of collagen heterogeneity and pendulum melanocytes, which were correlated with the presence of mast cells in the present study 19,20 . Our results suggest mast cells as playing a central role in the pathophysiology of melasma, and therapeutic trials with mastocyte stabilizers drugs are warranted.…”
Section: Fig 2 Melasma (A)mentioning
confidence: 54%
“…Mast cells also secret paracrine mediators factors that induce elastin production by fibroblasts 18 . In addition, mast cells produce tryptase, which participate in the damage to the extracellular matrix and basement membrane, (through matrix metallopeptidases 9-collagen IV damage), what can influence the occurrence of collagen heterogeneity and pendulum melanocytes, which were correlated with the presence of mast cells in the present study 19,20 . Our results suggest mast cells as playing a central role in the pathophysiology of melasma, and therapeutic trials with mastocyte stabilizers drugs are warranted.…”
Section: Fig 2 Melasma (A)mentioning
confidence: 54%
“…Melasma has a complex pathogenesis that surpasses melanocyte hypertrophy, and a combination of strategies can lead to more effective results. [24][25][26][27] Specific designs for assessing the long-term efficacy of cysteamine as well as its use as a maintenance treatment after other potent depigmenting agents (e.g., triple combination), laser or oral tranexamic acid are needed in order to position it among the existing strategies for the management of melasma. 15,28…”
Section: Discussionmentioning
confidence: 99%
“…V.13, N. 48 p. 435-443, Dezembro/2019 -ISSN 1981 88,88% das volutárias relataram ja terem feito algum tratamento e a avaliação na qualidade de vida foi de 44,44% de baixa autoestima. Apesar dos tratamentos disponíveis, recidivas são frequentes, o que causa impacto negativo na qualidade de vida da populaçao com melasma (ESPÓSITO, 2019;LIMA,2017).…”
Section: Resultsunclassified